A key drug is at the center of efforts to restrict abortion access. This drug is used in a common abortion method. Abortion opponents are trying to block providers from sending this drug to certain states.

The US Food and Drug Administration is reviewing rules related to this drug and may call for changes. A court case is also underway, with a panel of judges considering whether prescribing rules should be tightened.

Further details about these efforts are available from the source, including information about ongoing court cases and the FDA's review process.